kynostatin 272 has been researched along with indinavir sulfate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blum, LE; Clemente, JC; Dunn, BM; Goodenow, MM; Hemrajani, R | 1 |
| Anderson, B; Erickson, JW; Gulnik, SV; Liu, B; Mitsuya, H; Suvorov, LI; Yu, B | 1 |
| Burt, SK; Erickson, JW; Rick, SW; Topol, IA | 1 |
3 other study(ies) available for kynostatin 272 and indinavir sulfate
| Article | Year |
|---|---|
Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30N.
Topics: Alanine; Anti-HIV Agents; Asparagine; Aspartic Acid; Binding Sites; Drug Resistance, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoleucine; Kinetics; Methionine; Mutagenesis, Site-Directed; Nelfinavir; Ritonavir; Valine | 2003 |
Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure.
Topics: Amino Acid Sequence; Binding Sites; Carbamates; Cloning, Molecular; Drug Resistance, Microbial; HIV Protease; HIV Protease Inhibitors; HIV-1; Indinavir; Isoquinolines; Kinetics; Methylurea Compounds; Mutagenesis, Site-Directed; Oligopeptides; Point Mutation; Pyridines; Quinolines; Recombinant Proteins; Saquinavir; Structure-Activity Relationship; Thiazoles; Valine | 1995 |
Molecular mechanisms of resistance: free energy calculations of mutation effects on inhibitor binding to HIV-1 protease.
Topics: Computer Simulation; HIV Protease; HIV Protease Inhibitors; Humans; Indinavir; Kinetics; Models, Chemical; Models, Molecular; Molecular Conformation; Mutation; Oligopeptides; Saquinavir | 1998 |